FDA Device Intelligence
Home › Diagnostic Automation, Inc. › QMedix™

QMedix™

Diagnostic Automation, Inc. · Model DACD1444-2 · UDI-DI 00850054026644

LGC
10
510(k) clearances
13
Adverse events
7
Recalls
18
Facilities

Description

QMedix™ Herpes Simplex 1,2 IgM (HSV 1,2 IgM) ELISA is an enzyme-linked immunosorbent assay for the qualitative detection of IgM class antibodies to Herpes Simplex Virus (HSV) in human serum. This test is intended to be used to evaluate serologic evidence of primary or reactivated infection with HSV and is for In Vitro diagnostic use.

Recalls

DateFirmReason
2022-09-28Biokit, S.A.HSV-2 rapid test may report false positive results.
2012-01-16Diamedix CorporationOn 01/16/20112 Diamedix initiated a recall of IS-HSV 1&2 IgM Test Kit, Catalog # 720-350, Lot 60701, Exp. June 30, 2012. The Positive Control for this lot is Out of Specification.
2010-12-22BioCheck IncProduct labels indicate that the products are for IVD use and they do not have an approved 510(k).
2010-12-22BioCheck IncProduct labels indicate that the products are for IVD use and they do not have an approved 510(k).
2010-04-14Biokit U.S.A. Inc.Negative serum was giving a positive result Herpes Simplex Type 2 (HSV-2). It is possible that misdiagnosis (i.e., positive) could be made.
2010-04-14Biokit U.S.A. Inc.Negative serum was giving a positive result Herpes Simplex Type 2 (HSV-2). It is possible that misdiagnosis (i.e., positive) could be made.
2007-07-06Focus Diagnostics IncA small percentage of samples tested in specific lots, the HSV common antigen band appears lighter (less reactive) than the reading control band. Reduced reactivity of the common

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.